COM503 is a potential first-in-class, high affinity antibody targeting cytokine biology to enhance anti-tumor immunity in a differentiated manner. Compugen is headquartered in Israel, with offices in South San Francisco, CA. Compugen's shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN.CGEN Stock Message Board for Investors. Compugen Ltd. Stock Price, News and Company Updates. Message Board Total Posts: 57The Centre for Global Engineering (CGEN) is a multidisciplinary research institute at the University of Toronto which is mobilizing engineering researchers and students to solve the world's most intractable problems. Our mandate is two-fold: To catalyze cutting-edge engineering research, and produce evidence-based solutions to the Grand ...COM902/TIGIT. COM902 is a therapeutic antibody against the immuno-oncology target TIGIT, a recently validated immune checkpoint. Compugen is ultimately developing COM902 to broaden the clinical potential of its PVRIG inhibitor, COM701 allowing to comprehensively block the DNAM axis by the parallel inhibition of TIGIT and PVRIG.NCT04570839. Rasco Drew. W et al, ASCO annual meeting, June 2-6, 2023. May 25, 2023. Abstract: The combination of COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with recurrent, metastatic MSS endometrial cancer. NCT04570839.About Overview Leadership Collaborations Overview Leadership Collaborations Overview Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platforms to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy. Recognizing the potential of immuno-oncology ...Compugen Stock Jumps After Bristol Myers Squibb Invests $20M. (Investing.com) Nov-08-21 07:00AM. Compugen to Present at Upcoming Investor Conferences. (PR Newswire) Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United ...The Centre for Global Engineering (CGEN) is a multidisciplinary research institute at the University of Toronto which is mobilizing engineering researchers and students to solve the world's most intractable problems. Our mandate is two-fold: To catalyze cutting-edge engineering research, and produce evidence-based solutions to the Grand ...Based on short-term price targets offered by four analysts, the average price target for Compugen comes to $6.75. The forecasts range from a low of $3.00 to a high of $13.00. The average price ...Compugen Ltd. Annual balance sheet by MarketWatch. View all CGEN assets, cash, debt, liabilities, shareholder equity and investments.Corporate Overview. Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platform to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy. Recognizing the potential of immuno-oncology to shift the ...Based on short-term price targets offered by four analysts, the average price target for Compugen comes to $6.75. The forecasts range from a low of $3.00 to a high of $13.00. The average price ...Advancement of AZD2936, a PD-1/TIGIT bispecific antibody derived from COM902, into Phase 2, triggers $7.5 million milestone payment from AstraZeneca Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that it expects to receive a milestone payment of $7.5 million from AstraZeneca, after AstraZeneca dosed ...Analyst Forecast. According to 4 analysts, the average rating for CGEN stock is "Buy." The 12-month stock price forecast is $6.13, which is an increase of 483.81% from the latest price.Find the latest Compugen Ltd. (CGEN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Age in 2004: 59 to 76. Current Population: 41 million (declining) This generation had significant opportunities in jobs and education as the War ended and a. post-war economic boom struck America. However, the growth in Cold War tensions, the potential for nuclear war and other never before seen threats led to levels.CCGen generates credit card numbers using a few steps. First, let's look at the number distributions on the original credit cards: The first six numbers are the BIN, or issuer's ID number that remains the same for each debit card provided by the financial institution. The remaining 8 digits are referred to as the number of the cardholder.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Advancement of AZD2936, a PD-1/TIGIT bispecific antibody derived from COM902, into Phase 2, triggers $7.5 million milestone payment from AstraZeneca Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that it expects to receive a milestone payment of $7.5 million from AstraZeneca, after AstraZeneca dosed ...COM503 is a potential first-in-class, high affinity antibody targeting cytokine biology to enhance anti-tumor immunity in a differentiated manner. Compugen is headquartered in Israel, with offices in San Francisco, CA. Compugen's shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN. Forward-Looking StatementA troupe of neon-clad dancers in the CGEN dance company worked the stage with choreography inspired by the 1980s New York City ballroom scene.Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...Analyst Price Forecast Suggests 635.08% Upside. As of May 11, 2023, the average one-year price target for Compugen is 6.04. The forecasts range from a low of 0.50 to a high of $13.65. The average ...Collaboration is an important value for us, both externally and internally. Our culture, expertise and the relationships we build are the key ingredients to what makes us unique. We care about each other and have an open environment in Compugen. We invest in our talent and are passionate about professional and business growth.cgen offers a simple abstract syntax tree for C and related languages (C++/CUDA/OpenCL) to allow structured code generation from Python. To represent mathematical expressions, cgen can be used with pymbolic. cgen is licensed under the liberal MIT license and free for commercial, academic, and private use.COM503 is a potential first-in-class, high affinity antibody targeting cytokine biology to enhance anti-tumor immunity in a differentiated manner. Compugen is headquartered in Israel, with offices in San Francisco, CA. Compugen's shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN. Forward-Looking StatementHOLON, Israel, Feb. 14, 2023 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, reported today that ...walmart rhinelander
Compugen’s lead candidate, COM701, is a potentially first-in-class immunotherapy targeting PVRIG, a novel immune checkpoint that our team computationally discovered and validated in preclinical studies. Clinical data of COM701, as a monotherapy and in combination with PD-1 blockers, have demonstrated initial signs of antitumor activity, with ...To represent mathematical expressions, cgen can be used with pymbolic. Places on the web related to cgen: Python package index (download releases) Documentation (read how things work) Github (get latest source code, file bugs) cgen is licensed under the liberal MIT license and free for commercial, academic, and private use. All of cgen’s ...Nov 12, 2021 10:07AM EST. Shares of clinical-stage cancer immunotherapy company Compugen Ltd. CGEN jumped 14.01% after it announced that Bristol Myers Squibb BMY completed $20 million equity ...About Overview Leadership Collaborations Overview Leadership Collaborations Overview Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platforms to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy. Recognizing the potential of immuno-oncology ...CGEN (pronounced seejen) is a framework for developing generators of CPU-related tools such as assemblers, disassemblers and simulators.It specifies a description language for describing the architecture and organization of a CPU without reference to any particular application.CGEN earnings call for the period ending March 31, 2021. Motley Fool Transcribers | May 13, 2021 Compugen Ltd. (CGEN) Q4 2020 Earnings Call Transcript.Compugen (company) Compugen Ltd. ( Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993.Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that the European Patent Office has granted Compugen a new patent covering anti-PVRIG antibodies for use in cancer treatment. European Patent No. 3 653 221 link titled "Anti-PVRIG antibodies and Methods of Use" augments previously issued patents by ...The California Government Enterprise Network (CGEN) services is comprised of all network services provided by CDT such as: Vendor Managed WAN, SDWAN, FRS, DNS, VPN, CPI, etc. These services provide statewide network access and deliver network traffic to CDT Customer headquarters sites, CDT hosting facilities, the Internet, other state agencies ...View Compugen Ltd CGEN investment & stock information. Get the latest Compugen Ltd CGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.andromeda t.v. series
Compugen Ltd. (NASDAQ: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that Anat Cohen-Dayag, Ph.D., President and CEO, and additional members of its management team will participate in a virtual fireside chat at the upcoming JMP Securities Hematology and Oncology Summit. The fireside chat will take place on Tuesday, December ...Generation Z (often shortened to Gen Z ), colloquially known as zoomers, [1] [2] [3] is the demographic cohort succeeding Millennials and preceding Generation Alpha. Researchers and popular media use the mid-to-late 1990s as starting birth years and the early 2010s as ending birth years. Most members of Generation Z are children of Generation X ...This Billing and Coding Article provides billing and coding guidance for molecular pathology services, genomic sequencing procedures and other multianalyte assays, multianalyte assays with algorithmic analyses, and applicable proprietary laboratory analyses codes and Tier 1 and Tier 2 molecular pathology procedures.Compugen Ltd. Annual balance sheet by MarketWatch. View all CGEN assets, cash, debt, liabilities, shareholder equity and investments.A troupe of neon-clad dancers in the CGEN dance company worked the stage with choreography inspired by the 1980s New York City ballroom scene.A high-level overview of Compugen Ltd. (CGEN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.CGEN’s stock style is Small Core. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are ...A troupe of neon-clad dancers in the CGEN dance company worked the stage with choreography inspired by the 1980s New York City ballroom scene.vego
CCGen generates credit card numbers using a few steps. First, let's look at the number distributions on the original credit cards: The first six numbers are the BIN, or issuer's ID number that remains the same for each debit card provided by the financial institution. The remaining 8 digits are referred to as the number of the cardholder.Based on short-term price targets offered by four analysts, the average price target for Compugen comes to $6.75. The forecasts range from a low of $3.00 to a high of $13.00. The average price ...Creative Generation—State Schools Onstage (CGEN) continues to give students, teachers and school communities the opportunity to be involved in a professionally produced, award-winning arena spectacular. Since its inception in 2005, the large-scale event has grown from a cast of 550 students to now more than 1,800 and is nationally renowned ...Find the latest Compugen Ltd. (CGEN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Bioconductor version: Release (3.17) This is a package for analysis of case-control data in genetic epidemiology. It provides a set of statistical methods for evaluating gene-environment (or gene-genes) interactions under multiplicative and additive risk models, with or without assuming gene-environment (or gene-gene) independence in the ...Discover historical prices for CGEN stock on Yahoo Finance. View daily, weekly or monthly format back to when Compugen Ltd. stock was issued.The Centre for Global Engineering (CGEN) is a multidisciplinary research institute at the University of Toronto which is mobilizing engineering researchers and students to solve the world's most intractable problems. Our mandate is two-fold: To catalyze cutting-edge engineering research, and produce evidence-based solutions to the Grand ...HOLON, Israel, Jan. 18, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ-GM: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that the United States Patent and Trademark Office (USPTO) has granted Compugen a new patent covering method of use for COM701, Compugen's potential first-in-class therapeutic antibody targeting PVRIG, or back ...The CHARMM General Force Field (CGenFF) program performs atom typing and assignment of parameters and charges by analogy in a fully automated fashion. Atom typing is done by a deterministic programmable decision tree. Assignment of bonded parameters is based on substituting atom types in the definition of the desired parameter.CGEN and CDT Internet Access Policy Exemption Procedures. To obtain telecommunications services from a source other than CGEN, a non-exempt State entity must submit a CGEN Exemption service request and include the following information: Identify and describe the specific services needed, including the quantity, type, and location/street address ...Get the latest Compugen Ltd. (CGEN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Our multi-purpose random data generator serves the needs of developers, educators, and testers in the field of code programming and development. At present, Namso-Gen provides three types of generators: a Lorem ipsum generator, a user data generator, and a random test credit card generator. Our credit card generator, which uses the Luhn ...View Compugen Ltd CGEN investment & stock information. Get the latest Compugen Ltd CGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.cgen offers a simple abstract syntax tree for C and related languages (C++/CUDA/OpenCL) to allow structured code generation from Python. To represent mathematical expressions, cgen can be used with pymbolic. cgen is licensed under the liberal MIT license and free for commercial, academic, and private use.Find real-time CGEN - Compugen Ltd stock quotes, company profile, news and forecasts from CNN Business.COM902/TIGIT. COM902 is a therapeutic antibody against the immuno-oncology target TIGIT, a recently validated immune checkpoint. Compugen is ultimately developing COM902 to broaden the clinical potential of its PVRIG inhibitor, COM701 allowing to comprehensively block the DNAM axis by the parallel inhibition of TIGIT and PVRIG.HOLON, Israel, Jan. 18, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ-GM: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that the United States Patent and Trademark Office (USPTO) has granted Compugen a new patent covering method of use for COM701, Compugen's potential first-in-class therapeutic antibody targeting PVRIG, or back ...hart's war
Compugen Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. CGEN updated stock price target summary.Compugen Ltd. (NASDAQ:CGEN) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen’s Second Quarter 2023 Results ...Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will release its first quarter 2023 financial results on Monday, May 15, 2023, before the U.S. financial markets open. Management will host a conference call and webcast to review the results and provide a corporate update at ...The Centre for Global Engineering (CGEN) is a multidisciplinary research institute at the University of Toronto which is mobilizing engineering researchers and students to solve the world's most intractable problems. Our mandate is two-fold: To catalyze cutting-edge engineering research, and produce evidence-based solutions to the Grand ...CGEN Earnings Date and Information. Compugen last announced its earnings data on August 7th, 2023. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.02. Compugen has generated ($0.40) earnings per share over the last year ( ($0.40) diluted earnings per share).Sep 13, 2023 · A high-level overview of Compugen Ltd. (CGEN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. BREAKING NEWS. Chinese premier calls on China, Britain to properly handle disagreements. 1 hour ago. Morocco mourns quake victims as death toll climbs to over 2,000. 8 hours ago. Myanmar aims to hold elections after national census completed. 2 hours ago. HK activates mobilization protocol for civil servants on relief work. 4 hours ago.Corporate Overview. Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platform to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy. Recognizing the potential of immuno-oncology to shift the ... HOLON, Israel, Feb. 14, 2023 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, reported today that ...Analyst Price Forecast Suggests 635.08% Upside. As of May 11, 2023, the average one-year price target for Compugen is 6.04. The forecasts range from a low of 0.50 to a high of $13.65. The average ...Pfizer CEO Albert Bourla on Monday said the pharmaceutical giant will be able to deliver Seagen’s cancer therapy to the world “at a scale that has not been seen before” with its $43 billion ...CGEN Signals & Forecast. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development.CGEN Stock 12 Months Forecast. $4.00. (238.98% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Compugen in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 238.98% change from the last price of $1.18.Binutils/GDB developers wishing to use CGEN must configure Binutils/GDB with --enable-cgen-maint. This will add the necessary dependencies to opcodes/Makefile and sim/<arch>/Makefile for the supported processors. CGEN uses Guile so Guile must be installed. CGEN has been tested with Guile 1.4.1, 1.6.8, and 1.8.5.Our Triple Combination Approach. We believe that the PVRIG pathway we discovered is a potential paradigm shifting target to enhance patient responses to cancer immunotherapies and may provide new treatment options as monotherapy or in combination with other immune checkpoints to expand the reach of cancer immunotherapies to new patient populations.luckyland casino appThe Canadian Greenhouse Excellence Network (CGEN) is being positioned as a game-changing, strategic building block that will enable a greenhouse-specific roadmap and help meet the Government of Canada’s ambitious GHG emissions-reduction targets to 2030/2050 including: Canada’s 2030 AGENDA aims action towards the 17 UN Sustainable ...CGEN and CDT Internet Access Policy Exemption Procedures. To obtain telecommunications services from a source other than CGEN, a non-exempt State entity must submit a CGEN Exemption service request and include the following information: Identify and describe the specific services needed, including the quantity, type, and location/street address ...Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will release its first quarter 2023 financial results on Monday, May 15, 2023, before the U.S. financial markets open. Management will host a conference call and webcast to review the results and provide a corporate update at ...A troupe of neon-clad dancers in the CGEN dance company worked the stage with choreography inspired by the 1980s New York City ballroom scene.Generation Z (often shortened to Gen Z ), colloquially known as zoomers, [1] [2] [3] is the demographic cohort succeeding Millennials and preceding Generation Alpha. Researchers and popular media use the mid-to-late 1990s as starting birth years and the early 2010s as ending birth years. Most members of Generation Z are children of Generation X ...The surface of PES@CGEN-0% with continues polymer coating appears to be smooth and integrated, confirming the reliability of the preparation method. The PES@CGEN-20% exhibits typical sea-island structure within CGEN matrix due to the relatively low incorporation amount of the mUIO-66-NH 2 nanoparticles.CGEN | Complete Compugen Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BREAKING NEWS. Chinese premier calls on China, Britain to properly handle disagreements. 1 hour ago. Morocco mourns quake victims as death toll climbs to over 2,000. 8 hours ago. Myanmar aims to hold elections after national census completed. 2 hours ago. HK activates mobilization protocol for civil servants on relief work. 4 hours ago.Compugen Ltd. (NASDAQ:CGEN) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen’s Second Quarter 2023 Results ...Generation Z (often shortened to Gen Z ), colloquially known as zoomers, [1] [2] [3] is the demographic cohort succeeding Millennials and preceding Generation Alpha. Researchers and popular media use the mid-to-late 1990s as starting birth years and the early 2010s as ending birth years. Most members of Generation Z are children of Generation X ...May 1, 2023 · Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will release its first quarter 2023 financial results on Monday, May 15, 2023, before the U.S. financial markets open. Analyst Forecast. According to 4 analysts, the average rating for CGEN stock is "Buy." The 12-month stock price forecast is $6.13, which is an increase of 483.81% from the latest price.COM902/TIGIT. COM902 is a therapeutic antibody against the immuno-oncology target TIGIT, a recently validated immune checkpoint. Compugen is ultimately developing COM902 to broaden the clinical potential of its PVRIG inhibitor, COM701 allowing to comprehensively block the DNAM axis by the parallel inhibition of TIGIT and PVRIG.Pipeline. Despite significant advances in oncology, there is still a large unmet need in treating patients with solid tumors, especially those with advanced disease. Our approach begins with our proprietary computational discovery platform to identify new drug targets and biological pathways that could enhance anti-cancer immune responses. With ...Compugen (company) Compugen Ltd. ( Hebrew: קומפיוג'ן) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993.honey i blew up the kid
HOLON, Israel, June 1, 2020 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that the U.S ...Pfizer CEO Albert Bourla on Monday said the pharmaceutical giant will be able to deliver Seagen’s cancer therapy to the world “at a scale that has not been seen before” with its $43 billion ...Compugen Ltd. Annual balance sheet by MarketWatch. View all CGEN assets, cash, debt, liabilities, shareholder equity and investments.Creative Generation—State Schools Onstage (CGEN) Since its inception in 2005, the large-scale event has grown from a cast of 550 students to more than 1,800 and is nationally renowned for its outstanding and vibrant display of state school talent.The CHARMM General Force Field (CGenFF) program performs atom typing and assignment of parameters and charges by analogy in a fully automated fashion. Atom typing is done by a deterministic programmable decision tree. Assignment of bonded parameters is based on substituting atom types in the definition of the desired parameter.CGEN | Complete Compugen Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.CGEN does not currently support memory or cache profiling. Obviously they're important, and support may be added in the future. One thing that would be straightforward to add is the building of trace data for usage by cache and memory analysis tools. The point though is that these tools won't benefit much from CGEN's existence.Discover historical prices for CGEN stock on Yahoo Finance. View daily, weekly or monthly format back to when Compugen Ltd. stock was issued.Rilvegostomig. Compugen also has a clinical stage partnered program, rilvegostomig (previously AZD2936), a PD-1/TIGIT bi-specific derived from COM902, that is in Phase 2 development by AstraZeneca through a license agreement for the development of bi-specific and multi-specific antibodies. Study to Assess the Safety and Efficacy of AZD2936 in ...Discover historical prices for CGEN stock on Yahoo Finance. View daily, weekly or monthly format back to when Compugen Ltd. stock was issued.View the latest Car & General (Kenya) Ltd. (CGEN) stock price, news, historical charts, analyst ratings and financial information from WSJ.COM503 is a potential first-in-class, high affinity antibody targeting cytokine biology to enhance anti-tumor immunity in a differentiated manner. Compugen is headquartered in Israel, with offices in San Francisco, CA. Compugen's shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN. Forward-Looking Statementpitch perfect 2 where to watch
The rapid progress of the CGEN-15029 program, with extremely aggressive timelines from target discovery and validation to therapeutic antibody development, was made possible in large part by the identification of CGEN-15029's binding partner and the expansion of the Company's immuno-oncology R&D infrastructure.HOLON, Israel, Nov. 11, 2021 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that Bristol ...CGEN's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing.Compugen Ltd. analyst estimates, including CGEN earnings per share estimates and analyst recommendations.